Trial Profile
Effect of bivalirudin in patients with heparin-induced thrombocytopenia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 May 2015
Price :
$35
*
At a glance
- Drugs Bivalirudin (Primary)
- Indications Heparin-induced thrombocytopenia and thrombosis syndrome
- Focus Therapeutic Use
- 26 May 2015 New trial record